Randomized multicenter phase II trial comparing two schedules of etirinotecan pegol (NKTR-102) in women with recurrent platinum-resistant/refractory epithelial ovarian cancer
一项随机多中心II期临床试验，比较两种不同给药方案的依替替康聚乙二醇（NKTR-102）治疗复发性铂耐药/难治性上皮性卵巢癌女性患者的疗效。
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2012.45.1278
Vergote, Ignace B; Garcia, Agustin; Micha, John; Pippitt, Charles; Bendell, Johanna; Spitz, Daniel; Reed, Nicholas; Dark, Graham; Fracasso, Paula M; Ibrahim, Emad N; Armenio, Vincent A; Duska, Linda; Poole, Chris; Gennigens, Christine; Dirix, Luc Y; Leung, Abraham C F; Zhao, Carol; Soufi-Mahjoubi, Raoudha; Rustin, Gordon
